Goldhammer, Ehud <br/><br/>
The early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients.  [electronic resource] 

 -  Journal of cardiovascular medicine (Hagerstown, Md.)  Jun 2007 
 - 453-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1558-2027 
<br/><br/><label>Standard No.: </label>10.2459/JCM.0b013e3280111345  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-Antagonists--therapeutic use<br/>Adrenergic beta-Antagonists--therapeutic use<br/>Carbazoles--therapeutic use<br/>Carvedilol<br/>Heart Failure--drug therapy<br/>Humans<br/>Myocardial Infarction--drug therapy<br/>Propanolamines--therapeutic use<br/>Reactive Oxygen Species--metabolism<br/>Time Factors<br/>Treatment Outcome